New Study Reveals Genetic Risk Factor for Kidney Disease in West Africans

**A comprehensive study led by researchers from the National Institutes of Health (NIH) has *uncovered a significant genetic risk factor* for kidney disease among people from Ghana and Nigeria, contributing to the broader understanding of chronic kidney disease in individuals with West African ancestry.** The findings, published in the New England Journal of Medicine, indicate that possessing even just one variant in the APOL1 gene can considerably heighten the risk of developing chronic kidney disease. ### Background: While past research confirmed that APOL1 variants are linked with increased kidney disease risk among African Americans, this study fills a gap by focusing on West African populations. This is crucial since many African Americans have genetic lineage tracing back to West Africa. ### Study Details: - **Participants:** Over 8,000 individuals from Ghana and Nigeria, including nearly 5,000 with chronic kidney disease. - **Findings:** Around one-third of participants carried APOL1 variants that raise the risk of chronic kidney disease. Notably, a single variant in one copy of the APOL1 gene was enough to increase the risk by 18%, while having variants in both copies increased the risk by 25%. - **Impact:** The APOL1 variants significantly raise the likelihood of developing focal segmental glomerulosclerosis, a rare kidney condition. ### Implications: Dr. Adebowale A. Adeyemo of NIH emphasized that these insights enable a greater understanding of the genetic risks associated with kidney disease, potentially aiding earlier interventions and informed health decisions. As more than 37 million Americans suffer from chronic kidney disease, these findings are pivotal, especially for high-risk groups like African Americans. NIH's Paul Kimmel highlighted the importance of further research in the U.S. to understand the impact of APOL1 variants on kidney health, with a long-term goal of improving patient outcomes globally.